Class / Patent application number | Description | Number of patent applications / Date published |
514347000 | Chalcogen bonded directly to chalcogen | 11 |
20080249137 | PPAR active compounds - Compounds are described that are active on at least one of PPARα, PPARδ, and PPARγ, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARγ. | 10-09-2008 |
20080280956 | Heteroarylsulfonyl Stilbenes as 5-Ht2a Antagonists - Compounds of formula I: are potent and selective antagonists of the 5-HT | 11-13-2008 |
20090054495 | CCR9 inhibitors and methods of use thereof - The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods. | 02-26-2009 |
20100041713 | SUBSTITUTED AMINOTETRALINES - The invention is concerned with the compounds of formula I: | 02-18-2010 |
20120108640 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS - The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount, inactivating, and/or inhibiting the activity of a Na | 05-03-2012 |
20120202854 | 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES - Compounds of formula (I): | 08-09-2012 |
20120309796 | BENZOCYCLOHEPTENE ACETIC ACIDS - Provided herein are compounds of the formula (I): | 12-06-2012 |
20130102639 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES - The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of protein prenyltransferases including GGTase I and/or RabGGTase. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits. | 04-25-2013 |
20140080873 | TREATMENT OF CEREBRAL ISCHEMIA - The present invention relates to new compositions and methods for protecting neuronal cells from ischemic or hypoxic events. More precisely, this invention provides new combinatorial therapies that efficiently protect neuronal cells from ischemia or hypoxia. | 03-20-2014 |
20150057316 | NOVEL SULFONATE-BASED TRIMEBUTINE SALTS - The present description relates to compounds of Formula I (A | 02-26-2015 |
20160075647 | NOVEL PHENICOL ANTIBACTERIAL AGENTS - The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical compositions containing these novel compounds, and methods for the preparation of these compounds. | 03-17-2016 |